The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
84708098 8470809 8 F 201104 20160707 20120321 20160715 EXP CA-ROCHE-1050470 ROCHE 38.17 YR F Y 0.00000 20160715 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
84708098 8470809 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous S002F 103976 150 MG
84708098 8470809 2 SS XOLAIR OMALIZUMAB 1 Unknown S002F 103976
84708098 8470809 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous S002F 103976
84708098 8470809 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous S002F 103976
84708098 8470809 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous S002F 103976
84708098 8470809 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous S002F 103976 300 MG
84708098 8470809 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous S002F 103976
84708098 8470809 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous S002F 103976
84708098 8470809 9 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown 0
84708098 8470809 10 C SINGULAIR MONTELUKAST SODIUM 1 Unknown 0
84708098 8470809 11 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown 0
84708098 8470809 12 C ASMANEX MOMETASONE FUROATE 1 Unknown 0 QD
84708098 8470809 13 C ALVESCO CICLESONIDE 1 Unknown 0
84708098 8470809 14 C RHINARIS (CANADA) POLYETHYLENE GLYCOLS 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
84708098 8470809 1 Asthma
84708098 8470809 9 Product used for unknown indication
84708098 8470809 10 Product used for unknown indication
84708098 8470809 11 Product used for unknown indication
84708098 8470809 12 Product used for unknown indication
84708098 8470809 13 Product used for unknown indication
84708098 8470809 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
84708098 8470809 HO
84708098 8470809 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
84708098 8470809 Arthritis
84708098 8470809 Asthenia
84708098 8470809 Asthma
84708098 8470809 Candida infection
84708098 8470809 Cough
84708098 8470809 Dyspnoea
84708098 8470809 Hypertension
84708098 8470809 Lower respiratory tract infection
84708098 8470809 Obstructive airways disorder
84708098 8470809 Productive cough
84708098 8470809 Sciatica
84708098 8470809 Seasonal allergy
84708098 8470809 Upper respiratory tract infection
84708098 8470809 Weight decreased
84708098 8470809 Weight increased
84708098 8470809 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
84708098 8470809 1 20110126 0
84708098 8470809 2 20120410 0
84708098 8470809 3 20130523 0
84708098 8470809 4 20140401 0
84708098 8470809 5 20140506 0
84708098 8470809 7 20160608 0
84708098 8470809 8 20160707 0